Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page
- CheckyesterdayChange DetectedCMS revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision on the page updates from v3.4.2 to v3.4.3. This appears to be a site version or UI update rather than a change to study content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.4.2 was added; the government funding notice and Revision: v3.4.1 were removed. These changes affect only page presentation, not the study data.SummaryDifference0.5%

- Check51 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the software version updated to v3.4.1; the previous version v3.4.0 was removed.SummaryDifference0.6%

- Check58 days agoChange DetectedAdditions include a glossary option in the header and new QC-related metadata: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Deletions remove the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.3%

- Check72 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.